logo BDSP

Base documentaire


  1. Use of therapeutic drug monitoring in pharmacoeconomics.

    Article, Congrès - En anglais

    International congress of therapeutic drug monitoring and clinical toxicology. Philadelphia PA (USA), 1993/05/25.

    The use of therapeutic drug monitoring (TDM) for drugs with a narrow therapeutic range has contributed substantially to the literature.

    The pharmacoeconomics of this service for hospitalized patients has demonstrated significant hospital savings.

    Appropriate use of this pharmacy-based service has demonstrated savings, reduction in total length of hospitalization, and cost avoidance with aminoglycoside-induced nephrotoxicity.

    Use of a Clinical Pharmacokinetic Service (CPS) for inpatient theophylline therapy and outpatient anticonvulsant therapy documents the pharmacoeconomic benefits provided by this service to both in- and outpatients.

    This report will discuss current literature with regard to pharmacoeconomics and cost-benefit analysis of TDM.

    Mots-clés Pascal : Aminoglycoside, Antibiotique, Pharmacocinétique, Surveillance, Traitement, Biologie clinique, Milieu hospitalier, Economie santé, Rapport coût bénéfice, Epidémiologie

    Mots-clés Pascal anglais : Aminoglycoside, Antibiotic, Pharmacokinetics, Surveillance, Treatment, Clinical biology, Hospital environment, Health economy, Cost benefit ratio, Epidemiology

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 94-0134655

    Code Inist : 002B02S02. Création : 199406.